{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:14:45Z","timestamp":1791998085707,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004242","name":"Princess Nourah Bint Abdulrahman University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00210-025-04919-w","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T02:42:09Z","timestamp":1770345729000},"page":"10599-10614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The protective effect of ambroxol against cyclophosphamide-induced acute kidney injury involves Nrf2\/HO-1 signaling upregulation and suppression of oxidative and inflammatory damage"],"prefix":"10.1007","volume":"399","author":[{"given":"Reem S.","family":"Alruhaimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad H. M.","family":"Hassanein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulaiman M.","family":"Alnasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan S.","family":"Althagafy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Sabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullatif A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman M.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"9","key":"4919_CR1","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1080\/0886022X.2016.1216722","volume":"38","author":"SM Abd El-Twab","year":"2016","unstructured":"Abd El-Twab SM, Hozayen WG, Hussein OE, Mahmoud AM (2016) 18\u03b2-glycyrrhetinic acid protects against methotrexate-induced kidney injury by up-regulating the Nrf2\/ARE\/HO-1 pathway and endogenous antioxidants. Ren Fail 38(9):1516\u20131527","journal-title":"Ren Fail"},{"issue":"8","key":"4919_CR2","first-page":"838","volume":"13","author":"NG Abraham","year":"1985","unstructured":"Abraham NG, Lutton JD, Levere RD (1985) Heme metabolism and erythropoiesis in abnormal iron states: role of delta-aminolevulinic acid synthase and heme oxygenase. Exp Hematol 13(8):838\u2013843","journal-title":"Exp Hematol"},{"key":"4919_CR3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00280-016-3152-1","volume":"78","author":"M Ahlmann","year":"2016","unstructured":"Ahlmann M, Hempel G (2016) The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy. Cancer Chemother Pharmacol 78:661\u2013671","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"4919_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/ki.2014.285","volume":"87","author":"RS Al-Lamki","year":"2015","unstructured":"Al-Lamki RS, Mayadas TN (2015) TNF receptors: signaling pathways and contribution to renal dysfunction. Kidney Int 87(2):281\u2013296","journal-title":"Kidney Int"},{"key":"4919_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/biom9080346","author":"SH Aladaileh","year":"2019","unstructured":"Aladaileh SH, Abukhalil MH, Saghir SAM, Hanieh H, Alfwuaires MA, Almaiman AA, Bin-Jumah M, Mahmoud AM (2019) Galangin activates Nrf2 signaling and attenuates oxidative damage, inflammation, and apoptosis in a rat model of cyclophosphamide-induced hepatotoxicity. Biomolecules. https:\/\/doi.org\/10.3390\/biom9080346","journal-title":"Biomolecules"},{"key":"4919_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120071","volume":"286","author":"SH Aladaileh","year":"2021","unstructured":"Aladaileh SH, Al-Swailmi FK, Abukhalil MH, Ahmeda AF, Mahmoud AM (2021) Punicalagin prevents cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammatory response, and apoptosis in rats. Life Sci 286:120071","journal-title":"Life Sci"},{"key":"4919_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ph15111310","author":"AA Alanezi","year":"2022","unstructured":"Alanezi AA, Almuqati AF, Alfwuaires MA, Alasmari F, Namazi NI, Althunibat OY, Mahmoud AM (2022) Taxifolin prevents cisplatin nephrotoxicity by modulating Nrf2\/HO-1 pathway and mitigating oxidative stress and inflammation in mice. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph15111310","journal-title":"Pharmaceuticals (Basel)"},{"key":"4919_CR8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.biopha.2018.12.112","volume":"111","author":"HAS ALHaithloul","year":"2019","unstructured":"ALHaithloul HAS, Alotaibi MF, Bin-Jumah M, Elgebaly H, Mahmoud AM (2019) Olea europaea leaf extract up-regulates Nrf2\/ARE\/HO-1 signaling and attenuates cyclophosphamide-induced oxidative stress, inflammation and apoptosis in rat kidney. Biomed Pharmacother 111:676\u2013685","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"4919_CR9","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.4049\/jimmunol.172.4.2522","volume":"172","author":"K Asehnoune","year":"2004","unstructured":"Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E (2004) Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol (Baltimore, Md.\u202f: 1950) 172(4):2522\u20139","journal-title":"J Immunol (Baltimore, Md. : 1950)"},{"key":"4919_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/bs.vh.2022.09.002","volume":"121","author":"DA Averill-Bates","year":"2023","unstructured":"Averill-Bates DA (2023) The antioxidant glutathione. Vitam Horm 121:109\u2013141","journal-title":"Vitam Horm"},{"key":"4919_CR11","doi-asserted-by":"publisher","first-page":"5096825","DOI":"10.1155\/2022\/5096825","volume":"2022","author":"MA Ayza","year":"2022","unstructured":"Ayza MA, Zewdie KA, Yigzaw EF, Ayele SG, Tesfaye BA, Tafere GG, Abrha MG (2022) Potential Protective Effects of Antioxidants against Cyclophosphamide-Induced Nephrotoxicity. Int J Nephrol 2022:5096825","journal-title":"Int J Nephrol"},{"key":"4919_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0065-2776(08)60742-7","volume":"65","author":"PA Baeuerle","year":"1997","unstructured":"Baeuerle PA, Baichwal VR (1997) NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 65:111\u2013137","journal-title":"Adv Immunol"},{"issue":"5","key":"4919_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11255-019-02128-y","volume":"51","author":"EN Barut","year":"2019","unstructured":"Barut EN, Engin S, Barut B, Kaya C, Kerimoglu G, Ozel A, Kadioglu M (2019) Uroprotective effect of ambroxol in cyclophosphamide-induced cystitis in mice. Int Urol Nephrol 51(5):803\u2013810","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"4919_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1139\/cjpp-2018-0528","volume":"97","author":"A Bishr","year":"2019","unstructured":"Bishr A, Sallam N, Nour El-Din M, Awad AS, Kenawy SA (2019) Ambroxol attenuates cisplatin-induced hepatotoxicity and nephrotoxicity via inhibition of p-JNK\/p-ERK. Can J Physiol Pharmacol 97(1):55\u201364","journal-title":"Can J Physiol Pharmacol"},{"key":"4919_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","volume":"1263","author":"S Dallakyan","year":"2015","unstructured":"Dallakyan S, Olson AJ (2015) Small-molecule library screening by docking with PyRx. Methods Mol Biol 1263:243\u2013250","journal-title":"Methods Mol Biol"},{"issue":"11","key":"4919_CR16","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","volume":"6","author":"A Emadi","year":"2009","unstructured":"Emadi A, Jones RJ, Brodsky RA (2009) Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol 6(11):638\u2013647","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"4919_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.70017","volume":"85","author":"KG Faldu","year":"2024","unstructured":"Faldu KG, Shah JS (2024) Ambroxol improves amyloidogenic, NF-\u03baB, and Nrf2 pathways in a scopolamine-induced cognitive impairment rat model of Alzheimer\u2019s disease. Drug Dev Res 85(7):e70017","journal-title":"Drug Dev Res"},{"issue":"5","key":"4919_CR18","first-page":"381","volume":"123","author":"C Gultekin","year":"2022","unstructured":"Gultekin C, Sehirli AO, Cetinel S, Sayiner S (2022) Could ambroxol reduce cytokines in hepatic ischemia-reperfusion injury in rats? Bratisl Lek Listy 123(5):381\u2013384","journal-title":"Bratisl Lek Listy"},{"issue":"8","key":"4919_CR19","first-page":"1037","volume":"25","author":"\u00c7 G\u00fcltekin","year":"2022","unstructured":"G\u00fcltekin \u00c7, Sayiner S, \u00c7etinel \u015e, \u015eehirli A (2022) Does ambroxol alleviate kidney ischemia-reperfusion injury in rats? Iran J Basic Med Sci 25(8):1037\u20131041","journal-title":"Iran J Basic Med Sci"},{"issue":"1","key":"4919_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, Zeng C, Zhou T, Zhang J (2024) NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther 9(1):53","journal-title":"Signal Transduct Target Ther"},{"key":"4919_CR21","doi-asserted-by":"publisher","first-page":"5478708","DOI":"10.1155\/2020\/5478708","volume":"2020","author":"M Gyur\u00e1szov\u00e1","year":"2020","unstructured":"Gyur\u00e1szov\u00e1 M, Gureck\u00e1 R, B\u00e1b\u00ed\u010dkov\u00e1 J, T\u00f3thov\u00e1 \u013d (2020) Oxidative Stress in the Pathophysiology of Kidney Disease: Implications for Noninvasive Monitoring and Identification of Biomarkers. Oxid Med Cell Longev 2020:5478708","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"4919_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","volume":"62","author":"WK Han","year":"2002","unstructured":"Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV (2002) Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 62(1):237\u2013244","journal-title":"Kidney Int"},{"issue":"5","key":"4919_CR23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674","journal-title":"Cell"},{"key":"4919_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122209","volume":"334","author":"EH Hassanein","year":"2023","unstructured":"Hassanein EH, Ibrahim IM, Abd-Alhameed EK, Sharawi ZW, Jaber FA, Althagafy HS (2023) Nrf2\/HO-1 as a therapeutic target in renal fibrosis. Life Sci 334:122209","journal-title":"Life Sci"},{"issue":"6","key":"4919_CR25","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/j.transproceed.2013.04.007","volume":"45","author":"K Jiang","year":"2013","unstructured":"Jiang K, Wang X, Mao X, Lao H, Zhang J, Wang G, Cao Y, Tong I, Zhang F (2013) Ambroxol alleviates hepatic ischemia reperfusion injury by antioxidant and antiapoptotic pathways. Transplant Proc 45(6):2439\u20132445","journal-title":"Transplant Proc"},{"issue":"6","key":"4919_CR26","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T (2009) The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 1(6):a001651","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"4919_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1089\/ars.2016.6659","volume":"25","author":"JM Lever","year":"2016","unstructured":"Lever JM, Boddu R, George JF, Agarwal A (2016) Heme oxygenase-1 in kidney health and disease. Antioxid Redox Signal 25(3):165\u2013183","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"4919_CR28","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.3390\/ijms24076053","volume":"24","author":"D-W Lin","year":"2023","unstructured":"Lin D-W, Hsu Y-C, Chang C-C, Hsieh C-C, Lin C-L (2023) Insights into the molecular mechanisms of NRF2 in kidney injury and diseases. Int J Mol Sci 24(7):6053","journal-title":"Int J Mol Sci"},{"key":"4919_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212114","author":"SC Lin","year":"2024","unstructured":"Lin SC, Chang CC, Tsou SH, Chiu PY, Cheng JF, Hung HC, Chen WJ, Ho YJ, Lin CL (2024) Protective effects of ambroxol on A\u03b2 and \u03b1-synuclein-induced neurotoxicity through glucocerebrosidase activation in HT-22 hippocampal neuronal cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252212114","journal-title":"Int J Mol Sci"},{"key":"4919_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cotox.2017.11.002","volume":"7","author":"K Lingappan","year":"2018","unstructured":"Lingappan K (2018) NF-\u03baB in oxidative stress. Curr Opin Toxicol 7:81\u201386","journal-title":"Curr Opin Toxicol"},{"issue":"8","key":"4919_CR31","first-page":"656","volume":"11","author":"JH Liu","year":"2009","unstructured":"Liu JH, Xie CJ, Li L (2009) [Effects of ambroxol on renal function in children undergoing cardiopulmonary bypass]. Zhongguo Dang Dai Er Ke Za Zhi 11(8):656\u2013658","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"4919_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.biopha.2016.12.047","volume":"86","author":"AM Mahmoud","year":"2017","unstructured":"Mahmoud AM, Germoush MO, Alotaibi MF, Hussein OE (2017) Possible involvement of Nrf2 and PPAR\u03b3 up-regulation in the protective effect of umbelliferone against cyclophosphamide-induced hepatotoxicity. Biomed Pharmacother 86:297\u2013306","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"4919_CR33","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1039\/C9FO00114J","volume":"10","author":"AM Mahmoud","year":"2019","unstructured":"Mahmoud AM, Hussein OE, Abd El-Twab SM, Hozayen WG (2019) Ferulic acid protects against methotrexate nephrotoxicity via activation of Nrf2\/ARE\/HO-1 signaling and PPAR\u03b3, and suppression of NF-\u03baB\/NLRP3 inflammasome axis. Food Funct 10(8):4593\u20134607","journal-title":"Food Funct"},{"issue":"8","key":"4919_CR34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0009-9120(99)00075-2","volume":"32","author":"JM Mat\u00e9s","year":"1999","unstructured":"Mat\u00e9s JM, P\u00e9rez-G\u00f3mez C, N\u00fa\u00f1ez de Castro I (1999) Antioxidant enzymes and human diseases. Clin Biochem 32(8):595\u2013603","journal-title":"Clin Biochem"},{"issue":"7","key":"4919_CR35","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1089\/ars.2012.5149","volume":"20","author":"M Mittal","year":"2014","unstructured":"Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB (2014) Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 20(7):1126\u20131167","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"4919_CR36","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/toxsci\/kfu233","volume":"143","author":"A Moghe","year":"2015","unstructured":"Moghe A, Ghare S, Lamoreau B, Mohammad M, Barve S, McClain C, Joshi-Barve S (2015) Molecular mechanisms of acrolein toxicity: relevance to human disease. Toxicol Sci 143(2):242\u2013255","journal-title":"Toxicol Sci"},{"issue":"1","key":"4919_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","volume":"21","author":"MJ Morgan","year":"2011","unstructured":"Morgan MJ, Liu Z-G (2011) Crosstalk of reactive oxygen species and NF-\u03baB signaling. Cell Res 21(1):103\u2013115","journal-title":"Cell Res"},{"issue":"4","key":"4919_CR38","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/jamaneurol.2019.4611","volume":"77","author":"S Mullin","year":"2020","unstructured":"Mullin S, Smith L, Lee K, D\u2019Souza G, Woodgate P, Elflein J, H\u00e4llqvist J, Toffoli M, Streeter A, Hosking J et al (2020) Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized. Noncontrolled Trial, JAMA Neurol 77(4):427\u2013434","journal-title":"Noncontrolled Trial, JAMA Neurol"},{"issue":"6","key":"4919_CR39","first-page":"743","volume":"78","author":"CA Naughton","year":"2008","unstructured":"Naughton CA (2008) Drug-induced nephrotoxicity. Am Fam Physician 78(6):743\u2013750","journal-title":"Am Fam Physician"},{"issue":"5","key":"4919_CR40","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/0891-5849(95)00028-V","volume":"19","author":"D Nowak","year":"1995","unstructured":"Nowak D, Pierscinski G, Drzewoski J (1995) Ambroxol inhibits doxorubicin-induced lipid peroxidation in heart of mice. Free Radic Biol Med 19(5):659\u2013663","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"4919_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4110\/in.2009.9.1.12","volume":"9","author":"HO Pae","year":"2009","unstructured":"Pae HO, Chung HT (2009) Heme oxygenase-1: its therapeutic roles in inflammatory diseases. Immune Netw 9(1):12\u201319","journal-title":"Immune Netw"},{"issue":"4 Suppl","key":"4919_CR42","doi-asserted-by":"publisher","first-page":"S216","DOI":"10.1097\/CCM.0b013e318168e375","volume":"36","author":"N Pannu","year":"2008","unstructured":"Pannu N, Nadim MK (2008) An overview of drug-induced acute kidney injury. Crit Care Med 36(4 Suppl):S216\u2013S223","journal-title":"Crit Care Med"},{"issue":"2","key":"4919_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad099","volume":"5","author":"K Patzwaldt","year":"2023","unstructured":"Patzwaldt K, Berezhnoy G, Ionescu T, Schramm L, Wang Y, Owczorz M, Calder\u00f3n E, Poli S, Serna Higuita LM, Gonzalez-Menendez I et al (2023) Repurposing the mucolytic agent ambroxol for treatment of sub-acute and chronic ischaemic stroke. Brain Commun 5(2):fcad099","journal-title":"Brain Commun"},{"key":"4919_CR44","doi-asserted-by":"publisher","first-page":"1352032","DOI":"10.3389\/fmolb.2024.1352032","volume":"11","author":"S Punchai","year":"2024","unstructured":"Punchai S, Chaiyagot N, Artkaew N, Jusakul A, Cha\u2019on U, Thanan R, Vaeteewoottacharn K, Lert-Itthiporn W (2024) Iron-induced kidney cell damage: insights into molecular mechanisms and potential diagnostic significance of urinary FTL. Front Mol Biosci 11:1352032","journal-title":"Front Mol Biosci"},{"issue":"12","key":"4919_CR45","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","volume":"1863","author":"M Redza-Dutordoir","year":"2016","unstructured":"Redza-Dutordoir M, Averill-Bates DA (2016) Activation of apoptosis signalling pathways by reactive oxygen species. Biochimica Et Biophysica Acta (BBA) - Mol Cell Res 1863(12):2977\u20132992","journal-title":"Biochimica Et Biophysica Acta (BBA) - Mol Cell Res"},{"issue":"1\u20132","key":"4919_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11010-012-1250-x","volume":"365","author":"MU Rehman","year":"2012","unstructured":"Rehman MU, Tahir M, Ali F, Qamar W, Lateef A, Khan R, Quaiyoom A, Oday OH, Sultana S (2012) Cyclophosphamide-induced nephrotoxicity, genotoxicity, and damage in kidney genomic DNA of Swiss albino mice: the protective effect of Ellagic acid. Mol Cell Biochem 365(1\u20132):119\u2013127","journal-title":"Mol Cell Biochem"},{"key":"4919_CR47","doi-asserted-by":"crossref","unstructured":"\u015eah H, G\u00fclmez N, Say\u0131ner S, \u015eehirli A\u00d6, K\u00fckner A (2025) Mitigating Cisplatin-Induced Nephrotoxicity in Rats: A Comparative Study of Ambroxol and Coenzyme Q10 Effects. Cyprus Journal of Medical Sciences","DOI":"10.4274\/cjms.2025.2024-103"},{"issue":"6","key":"4919_CR48","doi-asserted-by":"publisher","DOI":"10.1093\/toxres\/tfae201","volume":"13","author":"AA Sahu","year":"2024","unstructured":"Sahu AA, Mukherjee A, Nirala SK, Bhadauria M (2024) Cyclophosphamide-induced multiple organ dysfunctions: unravelling of dose dependent toxic impact on biochemistry and histology. Toxicol Res 13(6):tfae201","journal-title":"Toxicol Res"},{"issue":"4","key":"4919_CR49","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5306\/wjco.v11.i4.190","volume":"11","author":"MLC Santos","year":"2020","unstructured":"Santos MLC, de Brito BB, da Silva FAF, Botelho A, de Melo FF (2020) Nephrotoxicity in cancer treatment: an overview. World J Clin Oncol 11(4):190\u2013204","journal-title":"World J Clin Oncol"},{"issue":"2","key":"4919_CR50","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.semnephrol.2018.12.010","volume":"39","author":"H Shen","year":"2019","unstructured":"Shen H, Scialis RJ, Lehman-McKeeman L (2019) Xenobiotic transporters in the kidney: function and role in toxicity. Semin Nephrol 39(2):159\u2013175","journal-title":"Semin Nephrol"},{"key":"4919_CR51","first-page":"737","volume":"3","author":"M Singh","year":"2014","unstructured":"Singh M, Kumar N, Shuaib M, Garg VK, Sharma A (2014) A review on renal protective agents for cyclophosphamide induced nephrotoxicity. World J Pharm Pharmaceut Sci 3:737\u2013747","journal-title":"World J Pharm Pharmaceut Sci"},{"issue":"4","key":"4919_CR52","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028535","volume":"101","author":"H Tang","year":"2022","unstructured":"Tang H, Yuan Z, Li J, Wang Q, Fan W (2022) The application of ambroxol hydrochloride combined with fiberoptic bronchoscopy in elderly patients with severe pneumonia: a meta-analysis and systematic review. Medicine (Baltimore) 101(4):e28535","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"4919_CR53","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.rbr.2016.04.009","volume":"57","author":"KA Teles","year":"2017","unstructured":"Teles KA, Medeiros-Souza P, Lima FAC, Ara\u00fajo BGd, Lima RAC (2017) Cyclophosphamide administration routine in autoimmune rheumatic diseases: a review. Rev Bras Reumatol 57(6):596\u2013604","journal-title":"Rev Bras Reumatol"},{"key":"4919_CR54","doi-asserted-by":"publisher","first-page":"1494114","DOI":"10.3389\/fimmu.2025.1494114","volume":"16","author":"S Ullah","year":"2025","unstructured":"Ullah S, Park TJ, Park JS, Atiq A, Ali J, Kang MH, Ali W, Choe K, Kim MO (2025) Ambroxol attenuates detrimental effect of LPS-induced glia-mediated neuroinflammation, oxidative stress, and cognitive dysfunction in mice brain. Front Immunol 16:1494114","journal-title":"Front Immunol"},{"issue":"6","key":"4919_CR55","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/CAD.0000000000000912","volume":"31","author":"G Voelcker","year":"2020","unstructured":"Voelcker G (2020) Causes and possibilities to circumvent cyclophosphamide toxicity. Anticancer Drugs 31(6):617\u2013622","journal-title":"Anticancer Drugs"},{"issue":"2","key":"4919_CR56","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"AC Wallace","year":"1995","unstructured":"Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8(2):127\u2013134","journal-title":"Protein Eng"},{"key":"4919_CR57","doi-asserted-by":"publisher","unstructured":"Wang Z, Yang M, Chen X, Xiao R, Dong Y, Chu M, Song G, Wang Y (2023) Polypharmacology of ambroxol in the treatment of COVID-19. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20221927","DOI":"10.1042\/BSR20221927"},{"key":"4919_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118630","volume":"264","author":"S Waz","year":"2021","unstructured":"Waz S, Heeba GH, Hassanin SO, Abdel-latif RG (2021) Nephroprotective effect of exogenous hydrogen sulfide donor against cyclophosphamide-induced toxicity is mediated by Nrf2\/HO-1\/NF-\u03baB signaling pathway. Life Sci 264:118630","journal-title":"Life Sci"},{"key":"4919_CR59","doi-asserted-by":"publisher","first-page":"1156346","DOI":"10.3389\/fneph.2023.1156346","volume":"3","author":"H Zhai","year":"2023","unstructured":"Zhai H, Ni L, Wu X (2023) The roles of heme oxygenase-1 in renal disease. Front Nephrol 3:1156346","journal-title":"Front Nephrol"},{"issue":"6","key":"4919_CR60","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.19364","volume":"6","author":"X Zhan","year":"2023","unstructured":"Zhan X, Zhang H, Maegawa GHB, Wang Y, Gao X, Wang D, Li J (2023) Use of ambroxol as therapy for Gaucher disease. JAMA Netw Open 6(6):e2319364","journal-title":"JAMA Netw Open"},{"key":"4919_CR61","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev-med-050214-013407","volume":"67","author":"A Zuk","year":"2016","unstructured":"Zuk A, Bonventre JV (2016) Acute Kidney Injury. Annu Rev Med 67:293\u2013307","journal-title":"Annu Rev Med"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04919-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04919-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04919-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:03:42Z","timestamp":1782101022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04919-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4919"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04919-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments comply with the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8523, revised 1996). The study was approved by the ethics committee of Al-Azhar University (AZ-AS\/PH-REC\/01\/25).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}